查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514897

鼻疫苗市场，按疫苗类型、交付方式、分销、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Nasal Vaccines Market, By Vaccine Type, By Delivery Method, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 357 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年鼻疫苗市场规模为4.189亿美元，2024年至2032年复合年增长率为8.56%。

鼻疫苗市场-市场动态

呼吸道感染盛行率上升推动市场成长

呼吸道感染的日益普及正在推动鼻疫苗市场的成长，因为这项技术提供了一种无针的免疫替代方案。据世界卫生组织称，呼吸道感染占全球死亡率的很大一部分，光是流感每年就造成约 29 万至 65 万人死亡。这种负担，加上人们对无针疫苗接种的日益偏好，正在推动鼻疫苗市场的发展。例如，最近发表在知名医学杂誌上的一项研究表明，RSV（呼吸道合胞病毒）鼻疫苗可有效保护婴儿，凸显了其潜力。随着与呼吸道疾病的斗争持续进行，鼻腔疫苗有望发挥更重要的作用。

鼻疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.56% 左右的复合年增长率成长

根据疫苗类型细分，预计减毒活疫苗将在 2023 年占据最大市场份额

根据交付方式细分，2023年喷雾为主导类型

按地区划分，北美是 2023 年的主要收入来源

鼻疫苗市场-区隔分析：

全球鼻疫苗市场根据疫苗类型、给药方式、分布和地区进行细分。

根据疫苗类型，市场分为五类：减毒活疫苗、灭活疫苗、次单位疫苗、重组疫苗和合併疫苗。减毒活疫苗是刺激强烈免疫反应的病毒的弱化版本，由于其具有持久免疫力的潜力，预计将显着增长。然而，经过工程设计含有可触发靶向免疫反应的特定抗原的重组疫苗也因其安全性和易于生产而受到关注。

根据输送方式，市场分为两类：喷雾和滴注。喷雾预计将成为鼻腔疫苗市场的主要输送方法。喷雾剂更容易给药，特别是对于儿童和那些讨厌针头的人，并确保疫苗在鼻腔内更广泛地分布，以获得最佳的免疫反应。

鼻疫苗市场 - 地理洞察

由于成熟的研究基础设施、政府对疫苗开发的资助以及新技术的高采用率，北美目前占据了巨大的份额。然而，亚太地区预计将出现最快的成长。这是由大量且不断增长的易患呼吸道疾病的人口、可支配收入增加以及政府促进儿童免疫计划的倡议等因素推动的。欧洲提供了一个稳定的市场，重点是健全的监管框架和先进的疫苗研究。由于越来越注重改善公共卫生基础设施和提高对疫苗接种益处的认识，拉丁美洲、中东和非洲的新兴市场提供了广泛的潜力。能够满足地区监管要求、解决负担能力问题并根据当地需求客製化交付系统的製造商将处于有利地位，能够进入这个不断扩大的市场。

鼻疫苗市场-竞争格局：

阿斯特捷利康（AstraZeneca）和赛诺菲巴斯德（Sanofi Pasteur）等製药巨头因其在疫苗开发和全球分销网络方面的经验而拥有强大的影响力。然而，规模较小的生技公司正在透过创新的输送系统和针对特定呼吸道疾病的利基疫苗取得重大进展。此外，学术机构和研究中心在开发新型鼻疫苗平台方面发挥着至关重要的作用。这些实体之间的策略合作变得越来越普遍，利用综合专业知识来加速研发。併购也是一个潜在因素，老牌企业寻求扩大其疫苗产品组合或获得有前景的新技术。这种竞争格局需要注重创新、策略合作伙伴关係，并致力于解决未满足的医疗需求，以便在不断增长的鼻疫苗市场中站稳脚跟。

最近的发展：

2023 年1 月，Bharat Biotech International Limited (BBIL) 和生物技术工业研究援助中心(BIRAC) 开发了iNNCOVACC，这是世界上第一个鼻内COVID-19 疫苗，获得批准用于初级2 剂方案和异源加强剂量。

2023年10月，Mylab和印度血清研究所推出了印度首款无针鼻流感疫苗Nasovac S4。该疫苗含有四种流感病毒株，可透过印度各地的医疗保健提供者和诊所获得，符合世界卫生组织的建议

目录

第一章：鼻疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疫苗类型分類的鼻腔疫苗市场片段
    • 以交付方式分類的鼻疫苗市场片段
    • 按分布分類的鼻腔疫苗市场片段
    • 按国家/地区分類的鼻疫苗市场摘要
    • 按地区分類的鼻腔疫苗市场片段
  • 竞争洞察

第 3 章：鼻腔疫苗主要市场趋势

  • 鼻疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 鼻疫苗市场限制
    • 市场限制影响分析
  • 鼻疫苗市场机会
  • 鼻疫苗市场未来趋势

第 4 章：鼻疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：鼻腔疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：鼻腔疫苗市场格局

  • 2023 年鼻疫苗市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：鼻腔疫苗市场 - 依疫苗类型

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 减毒活疫苗
    • 灭活疫苗
    • 亚基
    • 重组
    • 结合疫苗

第 8 章：鼻腔疫苗市场 - 依交付方式

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 喷
    • 降低

第 9 章：鼻腔疫苗市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 民众
    • 私人的

第 10 章：鼻腔疫苗市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美鼻疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疫苗类型）
    • 北美市场规模和预测（按交付方式）
    • 北美市场规模和预测（按分布）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲鼻疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按疫苗类型）
    • 欧洲市场规模和预测（按交付方式）
    • 欧洲市场规模和预测（按分布）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区鼻疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依疫苗类型）
    • 亚太地区市场规模与预测（以交付方式）
    • 亚太地区市场规模与预测（按分布）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲鼻疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疫苗类型）
    • 拉丁美洲市场规模和预测（以交付方式）
    • 拉丁美洲市场规模与预测（按分布）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲鼻疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疫苗类型）
    • 中东和非洲市场规模及预测（以交付方式）
    • 中东和非洲市场规模及预测（按分布）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 鼻疫苗产业

  • 竞争仪表板
  • 公司简介
    • Altimmune Inc.
    • AstraZeneca PLC
    • Bharat Biotech International Limited
    • BioDiem, Inc.
    • CanSino Biopharmaceuticals Inc.
    • GlaxoSmithKline plc
    • Iovance Biotherapeutics, Inc.
    • Meda Pharma GmbH
    • MeDiVac, Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Seqirus Holdings Pty Ltd
    • Serum Institute of India Pvt. Ltd.
    • TransBio Inc.
    • Vaxlive Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3027

REPORT HIGHLIGHT

Nasal Vaccines Market size was valued at USD 418.9 million in 2023, expanding at a CAGR of 8.56% from 2024 to 2032.

Nasal vaccines, delivered as a spray or mist through the nose, offer a needle-free and potentially more efficient way to trigger immune responses. The growing preference for needle-free vaccinations, particularly among children and needle-phobic individuals. Additionally, nasal vaccines' ability to induce mucosal immunity, potentially providing better protection against respiratory illnesses, fuels market growth. However, challenges like ensuring the stability of the vaccine and navigating stringent regulatory pathways may act as restraints. Exciting opportunities lie in advancements in delivery systems for improved efficacy and the development of vaccines for various respiratory diseases, including COVID-19.

Nasal Vaccines Market- Market Dynamics

Rising prevalence of respiratory infections propelling the market growth

The increasing prevalence of respiratory infections is fueling the growth of the nasal vaccine market, as this technology offers a needle-free alternative to immunization. According to the World Health Organization, respiratory infections account for a significant portion of global mortality, with influenza alone causing an estimated 290,000 to 650,000 deaths annually. This burden, coupled with a growing preference for needle-free vaccinations, is driving the nasal vaccine market. For instance, a recent study published in a reputable medical journal demonstrated that a nasal vaccine for RSV (respiratory syncytial virus) proved effective in protecting infants, highlighting the potential of this. As the fight against respiratory illnesses continues, nasal vaccines are poised to play a more prominent role.

Nasal Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.56% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Live attenuated vaccines were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Spray was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Nasal Vaccines Market- Segmentation Analysis:

The Global Nasal Vaccines Market is segmented based on Vaccine Type, Delivery Method, Distribution, and Region.

The market is divided into five categories based on Vaccine Type: Live attenuated vaccines, Inactivated vaccines, Subunit, Recombinant, and Conjugate Vaccines. Live attenuated vaccines, weakened versions of the virus that stimulate a strong immune response, are expected to see significant growth due to their potential for long-lasting immunity. However, recombinant vaccines, engineered to contain specific antigens that trigger a targeted immune response, are also gaining traction due to their safety profile and ease of production.

The market is divided into two categories based on the Delivery Method: Spray and Drop. Spray is anticipated to be the dominant delivery method in the nasal vaccine market. Sprays offer greater ease of administration, particularly for children and those with needle aversion, and ensure a wider distribution of the vaccine within the nasal cavity for optimal immune response.

Nasal Vaccines Market- Geographical Insights

North America currently holds a significant share due to established research infrastructure, government funding for vaccine development, and a high adoption rate of new technologies. However, the Asia Pacific region is expected to witness the fastest growth. This is driven by factors like a large and growing population susceptible to respiratory illnesses, rising disposable income, and government initiatives promoting childhood immunization programs. Europe presents a steady market with a focus on robust regulatory frameworks and advanced vaccine research. Emerging markets in Latin America and the Middle East & Africa offer promising potential due to a growing focus on improving public health infrastructure and increasing awareness of vaccination benefits. Manufacturers who can navigate regional regulatory requirements, address affordability concerns, and tailor their delivery systems to suit local needs will be well-positioned to tap into this expanding market.

Nasal Vaccines Market- Competitive Landscape:

Pharmaceutical giants like AstraZeneca and Sanofi Pasteur hold a strong presence due to their experience in vaccine development and global distribution networks. However, smaller biotechnology companies are making significant strides with innovative delivery systems and niche vaccines targeting specific respiratory illnesses. Additionally, academic institutions and research centers play a crucial role in developing novel nasal vaccine platforms. Strategic collaborations between these entities are becoming increasingly common, leveraging combined expertise to accelerate research and development. Mergers and acquisitions are also a potential factor, with established players seeking to expand their vaccine portfolios or gain access to promising new technologies. This competitive landscape necessitates a focus on innovation, strategic partnerships, and a commitment to addressing unmet medical needs to gain a foothold in the growing nasal vaccine market.

Recent Developments:

In January 2023, Bharat Biotech International Limited (BBIL) and Biotechnology Industry Research Assistance (BIRAC) developed iNNCOVACC, the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule and as a heterologous booster dose.

In October 2023, Mylab and Serum Institute of India launched Nasovac S4, India's first needle-free nasal influenza vaccine. The vaccine contains four influenza virus strains and is available through healthcare providers and clinics across India, aligning with WHO recommendations

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NASAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Altimmune Inc.

AstraZeneca PLC

Bharat Biotech International Limited

BioDiem, Inc.

CanSino Biopharmaceuticals Inc.

GlaxoSmithKline plc

Iovance Biotherapeutics, Inc.

Meda Pharma GmbH

MeDiVac, Inc.

Pfizer Inc.

Sanofi S.A.

Seqirus Holdings Pty Ltd

Serum Institute of India Pvt. Ltd.

TransBio Inc.

Vaxlive Inc.

Others

GLOBAL NASAL VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live attenuated vaccines
  • Inactivated vaccines
  • Subunit
  • Recombinant
  • Conjugate Vaccines

GLOBAL NASAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Spray
  • Drop

GLOBAL NASAL VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Public
  • Private

GLOBAL NASAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nasal Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nasal Vaccines Market Snippet by Vaccine Type
    • 2.1.2. Nasal Vaccines Market Snippet by Delivery Method
    • 2.1.3. Nasal Vaccines Market Snippet by Distribution
    • 2.1.4. Nasal Vaccines Market Snippet by Country
    • 2.1.5. Nasal Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Nasal Vaccines Key Market Trends

  • 3.1. Nasal Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nasal Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nasal Vaccines Market Opportunities
  • 3.4. Nasal Vaccines Market Future Trends

4. Nasal Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nasal Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nasal Vaccines Market Landscape

  • 6.1. Nasal Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nasal Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Live attenuated vaccines
    • 7.1.3. Inactivated vaccines
    • 7.1.4. Subunit
    • 7.1.5. Recombinant
    • 7.1.6. Conjugate Vaccines

8. Nasal Vaccines Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. Spray
    • 8.1.3. Drop

9. Nasal Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Public
    • 9.1.3. Private

10. Nasal Vaccines Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nasal Vaccines Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nasal Vaccines Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nasal Vaccines Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Nasal Vaccines Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Nasal Vaccines Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Nasal Vaccines Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Altimmune Inc.
    • 11.2.2. AstraZeneca PLC
    • 11.2.3. Bharat Biotech International Limited
    • 11.2.4. BioDiem, Inc.
    • 11.2.5. CanSino Biopharmaceuticals Inc.
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Iovance Biotherapeutics, Inc.
    • 11.2.8. Meda Pharma GmbH
    • 11.2.9. MeDiVac, Inc.
    • 11.2.10. Pfizer Inc.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Seqirus Holdings Pty Ltd
    • 11.2.13. Serum Institute of India Pvt. Ltd.
    • 11.2.14. TransBio Inc.
    • 11.2.15. Vaxlive Inc.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nasal Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Nasal Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Delivery Method Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Delivery Method
  • TABLE Global Nasal Vaccines Market, by Delivery Method 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Nasal Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nasal Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)

List of Figures

  • FIGURE Nasal Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2032
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Delivery Method segment market share analysis, 2023 & 2032
  • FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Nasal Vaccines Market share and leading players, 2023
  • FIGURE Europe Nasal Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Nasal Vaccines Market share and leading players, 2023
  • FIGURE Latin America Nasal Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Nasal Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Germany Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Nasal Vaccines Market share analysis by country, 2023
  • FIGURE India Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)